Purple Innovation, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
Purple Innovation announced its second quarter 2026 financial results, showing showroom revenue growth but a decline in overall net revenue, leading to a revised, lower revenue forecast for the full year.
NASDAQ
Purple Innovation, Inc. has received a conditional reprieve from Nasdaq delisting, contingent on maintaining a $1.00 bid price following a 1-for-25 reverse stock split.
NASDAQ
Purple Innovation, Inc. has officially filed a Certificate of Amendment to implement a 1-for-25 reverse stock split, effective July 19, 2026, with trading on a split-adjusted basis commencing July 20, 2026.
NASDAQ
Purple Innovation, Inc. announced the approval of its board of directors, executive compensation, and independent auditor at its annual meeting on June 9, 2026.
NASDAQ
Purple Innovation, Inc. announced the resignation of Chief Operating Officer Eric Haynor, effective June 5, 2026.
NASDAQ
Purple Innovation, Inc. has received a delisting determination from Nasdaq due to its stock price falling below $1.00 for 30 consecutive business days, with an appeal planned.
NASDAQ
Purple Innovation, Inc. announced the appointment of Robert G. Lucian as its new CFO and reported first quarter 2026 financial results, including a revised revenue outlook for the year.
NASDAQ
Purple Innovation secured a debt maturity extension to April 2027 and reported a 9.1% revenue increase in Q4 2025, alongside positive full-year adjusted EBITDA.
NASDAQ
Purple Innovation, Inc. received a notice from Nasdaq regarding non-compliance with the minimum bid price rule, risking potential delisting.
NASDAQ
Purple Innovation reports third quarter 2025 results, showing an improved net loss and positive adjusted EBITDA, driven by product momentum and strategic partnerships.
NASDAQ
Purple Innovation, Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement, avoiding potential delisting.
NASDAQ
Purple Innovation, Inc. has amended employment and restricted share unit agreements for key executives, revising change in control definitions and vesting conditions.
NASDAQ
Purple Innovation, Inc. announced its second quarter 2025 financial results, reporting a 12.6% decline in net revenue and a significant net loss, despite an improvement in Adjusted EBITDA and strong demand for its new Rejuvenate 2.0 collection.
NASDAQ
Purple Innovation, Inc. has amended special bonus arrangements for its three named executive officers, deferring a significant portion of their August 2025 bonuses to January 2026 in exchange for an additional 15% payment and continued service.
NASDAQ
Purple Innovation, Inc. has approved significant long-term incentive cash bonus awards for its key executives, tied to cumulative net revenue, adjusted EBITDA, and EBITDA margin performance through 2027.
NASDAQ
Purple Innovation, Inc. announced that its stockholders approved all proposals at the Annual Meeting on June 10, 2025, including the election of nine directors, advisory approval of executive compensation, and ratification of BDO USA, LLP as independent auditor.
NASDAQ
Purple Innovation's board has accelerated the expiration date of its stockholder rights agreement and protective charter amendment to May 7, 2025, determining they are no longer necessary to protect net operating losses and could impede strategic alternatives.
NASDAQ
Purple Innovation reports a 13.2% decrease in Q1 net revenue but exceeds adjusted EBITDA target and reaffirms 2025 guidance, driven by improved gross margins and cost control.
NASDAQ
Purple Innovation, Inc. announces an expanded commercial relationship with Somnigroup, including increased presence in Mattress Firm stores and a strategic supply agreement with Tempur Sherwood, alongside securing $20 million in new debt financing.
NASDAQ
Purple Innovation, Inc. received notice from Nasdaq for non-compliance with minimum bid price requirements, potentially leading to delisting.
NASDAQ
Purple Innovation expands its credit facility with a $19 million loan increase and issues warrants to lenders.
NASDAQ
Purple Innovation's Board of Directors initiates a review of strategic alternatives following inbound expressions of interest, while also reporting positive Adjusted EBITDA and cash flow in Q4 2024.
NASDAQ
Purple Innovation (PRPL) has received notification from NASDAQ that it has regained compliance with the minimum bid price rule after its common stock price remained above $1.00 for ten consecutive business days.
NASDAQ
Purple Innovation has adjusted its full-year 2024 revenue and adjusted EBITDA guidance, while also announcing its participation in the ICR Conference.
NASDAQ
Purple Innovation, Inc. announced positive year-over-year sales results for the period leading up to Cyber Monday and reaffirmed its commitment to achieving the lower end of its previously announced 2024 net revenue and adjusted EBITDA guidance.
NASDAQ
Purple Innovation, Inc. has been notified by Nasdaq that its stock price has fallen below the required minimum of $1.00 per share for 30 consecutive business days, potentially leading to delisting if not rectified.
NASDAQ
Purple Innovation's third quarter results show a revenue decline but significant margin improvements driven by restructuring efforts.
NASDAQ
Purple Innovation, Inc. has amended its charter and ratified a stockholder rights plan to protect its net operating loss carryforwards by restricting certain stock transfers.
NASDAQ
Purple Innovation will consolidate its mattress production into its Georgia facility, closing two Utah plants, to streamline operations and generate cost savings.
NASDAQ
Purple Innovation saw a 2% increase in net revenue and a significant improvement in profitability in the second quarter of 2024, despite a challenging industry environment.